Sandbox: wdx causes: Difference between revisions

Latest revision as of 21:38, 17 September 2018

Differentiating Leukocytosis from Other Diseases

Category	Condition	Etiology	Mechanism				Congenital	Acquried	Clinical manifestations											Para−clinical findings								Gold standard	Associated findings
									Demography	History	Symptoms			Signs						Para−clinical findings
											Symptoms			Signs						Lab Findings
			Physiologic	Increased bone marrow production		Demargination of peripheral blood neutrophils					Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other	CBC			PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT
			Physiologic	Autonomous	Reactive	Demargination of peripheral blood neutrophils					Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT
Hematologic	Hereditary neutrophilia	Unknown Germline mutation in CSF3R	-	+	--	-	+	-	Rare autosomal dominant genetic disorder	Positive family history	Normal	-	-	Nl	-	+	-	-	-	↑	Nl	Nl	Normal granulocytes Histiocytes of Gaucher type	Nl	Nl	Nl	Nl	Genetic study	High leukocyte alkaline phosphatase Progress to leukemia
	Hereditary chronic neutrophilia
	Myeloproliferative neoplasms
	Polycythemia vera
	Microangiopathic hemolytic anemia (MAHA)
	Leukoerythroblastosis
	Immune thrombocytopenia
Immunology/ Rheumatology	Condition	Etiology	Physiologic	Autonomous increased bone marrow production	Reactive increased bone marrow production	Demargination of peripheral blood neutrophils	Congenital	Acquried	Demography	History	Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other signs	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT	Gold standard	Associated findings
	Leukocyte adhesion deficiency
	Cryopyrin-associated periodic syndromes
	Rheumatoid arthritis
	Juvenile onset rheumatoid arthritis
	Adult Still's disease
	Kawasaki disease
	IBD
	Sarcoidosis
	Chronic hepatitis
	Sweet syndrome
	Acute gout
Infection	Condition	Etiology	Physiologic	Autonomous increased bone marrow production	Reactive increased bone marrow production	Demargination of peripheral blood neutrophils	Congenital	Acquried	Demography	History	Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other signs	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT	Gold standard	Associated findings
	Acute bacterial																						toxic granulations, Döhle bodies, and cytoplasmic vacuoles in neutrophils
	Chronic infection
	Viral infection
	Granulomatous infections
	Bronchiectasis
Metabolic	Diabetic coma
	Acidosis
	Thyroid storm
	Hypercortisolism
	Seizures
Medication	Condition	Etiology	Physiologic	Autonomous increased bone marrow production	Reactive increased bone marrow production	Demargination of peripheral blood neutrophils	Congenital	Acquried	Demography	History	Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other signs	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT	Gold standard	Associated findings
	Steriod	Release of granulocytes from the bone marrow
	Myeloid growth factors
	Lithium
	Cytokines
	Catecholamines (epinephrine)	Stimulation of bone marrow myelopoiesis Egress into the circulation
	ATRA
Other	Condition	Etiology	Physiologic	Autonomous increased bone marrow production	Reactive increased bone marrow production	Demargination of peripheral blood neutrophils	Congenital	Acquried	Demography	History	Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other signs	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT	Gold standard	Associated findings
	Allergy
	Post splenectomy
	Down syndrome
	Cigarette smoking
	Stress/exercise
	Infancy
	Pregnancy
	Platelet clumping	Spurious
	Mixed cryoglobulinemia	Spurious
Category	Condition	Etiology	Physiologic	Autonomous increased bone marrow production	Reactive increased bone marrow production	Demargination of peripheral blood neutrophils	Congenital	Acquried	Demography	History	Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other signs	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT	Gold standard	Associated findings

@@ Line 1: / Line 1: @@
-== Metabolic Alkalosis ==
+==Differentiating Leukocytosis from Other Diseases==
-'''''Differential diagnosis of metabolic alkalosis is as follow''''':<ref name="pmid10665945">{{cite journal |vauthors=Galla JH |title=Metabolic alkalosis |journal=J. Am. Soc. Nephrol. |volume=11 |issue=2 |pages=369–75 |date=February 2000 |pmid=10665945 |doi= |url=}}</ref>
 {|
-! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category
+! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
-! colspan="2" rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease
+! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition
-! colspan="4" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Mechanism
+! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
-! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical
+! colspan="4" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mechanism
-! colspan="12" align="center" style="background:#4479BA; color: #FFFFFF;" + |Paraclinical
+! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
-! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard diagnosis
+! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
-! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other findings
+! colspan="11" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
+! colspan="8" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para−clinical findings
+! colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
+! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
 |-
-! colspan="3" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms
+! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
-! colspan="3" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Signs
+! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
-! colspan="12" align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab data
+! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
+| colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs
 |-
-! colspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |ABG
+! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
-! colspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" + |Chemistry
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Enzyme
-! colspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Renal function
 |-
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hydrogen loss
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Accumulation of base
+! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Increased bone marrow production
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Chloride depletion
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mineralocorticoid excess
+! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fever
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dyspnea
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Edema
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Toxic/ill
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |BP
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dehydration
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |HCO<sub>3</sub><sup>−</sup>
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |paCO<sub>2</sub>
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |O<sub>2</sub>
+! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Cl<sup>−</sup>
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |K<sup>+</sup>
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Na<sup>+</sup>
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ca<sup>+</sup>
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mg<sup>+</sup>
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Renin
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Bun
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Cr
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Urine Cl<sup>−</sup>
 |-
-! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Exogenous HCO<sub><big>3</big></sub><sup>−</sup> loads
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous
-! colspan="2" align="center" style="background:#DCDCDC;" + |Acute alkali administration<ref name="MáttarWeil1974">{{cite journal|last1=Máttar|first1=João A.|last2=Weil|first2=Max Harry|last3=Shubin|first3=Herbert|last4=Stein|first4=Leon|title=Cardiac arrest in the critically III|journal=The American Journal of Medicine|volume=56|issue=2|year=1974|pages=162–168|issn=00029343|doi=10.1016/0002-9343(74)90593-2}}</ref>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive
-| align="center" style="background:#F5F5F5;" + |−
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
+|-
+! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hematologic
+! align="center" style="background:#DCDCDC;" |[[Granulocytosis|Hereditary neutrophilia]]
+| align="center" style="background:#F5F5F5;" + |
+* Unknown
+* Germline mutation in [[CSF3R]]
+| align="center" style="background:#F5F5F5;" + | -
 | align="center" style="background:#F5F5F5;" + | +
-| align="center" style="background:#F5F5F5;" + |−
+| align="center" style="background:#F5F5F5;" + | --
-| align="center" style="background:#F5F5F5;" + |−
+| align="center" style="background:#F5F5F5;" + | -
-| align="center" style="background:#F5F5F5;" + | −
 | align="center" style="background:#F5F5F5;" + | +
-| align="center" style="background:#F5F5F5;" + |−
-| align="center" style="background:#F5F5F5;" + | +
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + | -
+| align="center" style="background:#F5F5F5;" + |Rare [[Dominance relationship|autosomal dominant]] genetic disorder
+| align="center" style="background:#F5F5F5;" + |
+* Positive family history
+| align="center" style="background:#F5F5F5;" + |Normal
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |+
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |-
 | align="center" style="background:#F5F5F5;" + |↑
-| align="center" style="background:#F5F5F5;" + |↑
-| align="center" style="background:#F5F5F5;" + |↓
-| align="center" style="background:#F5F5F5;" + |↓
-| align="center" style="background:#F5F5F5;" + |↓
-| align="center" style="background:#F5F5F5;" + |↓
-| align="center" style="background:#F5F5F5;" + |↑
 | align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |
+* Normal [[Granulocyte|granulocytes]]
+* [[Histiocyte|Histiocytes]] of Gaucher type
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |[[Genetics|Genetic]] study
+| align="center" style="background:#F5F5F5;" + |
+* High [[leukocyte alkaline phosphatase]]
+* Progress to [[leukemia]]
+|-
+! align="center" style="background:#DCDCDC;" |Hereditary chronic neutrophilia
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+|-
+! align="center" style="background:#DCDCDC;" |[[Myeloproliferative neoplasm|Myeloproliferative neoplasms]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+|-
+! align="center" style="background:#DCDCDC;" |[[Polycythemia vera]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+|-
+! align="center" style="background:#DCDCDC;" |[[Microangiopathic hemolytic anemia]] (MAHA)
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+|-
+! align="center" style="background:#DCDCDC;" |Leukoerythroblastosis
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+|-
+! align="center" style="background:#DCDCDC;" |Immune thrombocytopenia
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+|-
+! rowspan="12" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunology/
+Rheumatology
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous increased bone marrow production
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive increased bone marrow production
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
+|-
+! align="center" style="background:#DCDCDC;" |[[Leukocyte adhesion deficiency]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+|-
+! align="center" style="background:#DCDCDC;" |Cryopyrin-associated periodic syndromes
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+|-
+! align="center" style="background:#DCDCDC;" |[[Rheumatoid arthritis]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+|-
+! align="center" style="background:#DCDCDC;" |[[Juvenile rheumatoid arthritis|Juvenile onset rheumatoid arthritis]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
-| align="center" style="background:#F5F5F5;" + |↑
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Clinical
-| align="left" style="background:#F5F5F5;" + |
-* Post treatment of [[lactic acidosis]] or [[ketoacidosis]]
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Milk−alkali syndrome<ref name="Abreo1993">{{cite journal|last1=Abreo|first1=Kenneth|title=The Milk-Alkali Syndrome|journal=Archives of Internal Medicine|volume=153|issue=8|year=1993|pages=1005|issn=0003-9926|doi=10.1001/archinte.1993.00410080065011}}</ref>
+! align="center" style="background:#DCDCDC;" |[[Still's disease|Adult Still's disease]]
-| align="center" style="background:#F5F5F5;" + |−
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | −
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | −
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |−
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 94: / Line 443: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Transfusion<ref name="pmid14712429">{{cite journal |vauthors=Gupta M, Wadhwa NK, Bukovsky R |title=Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate |journal=Am. J. Kidney Dis. |volume=43 |issue=1 |pages=67–73 |date=January 2004 |pmid=14712429 |doi= |url=}}</ref>
+! align="center" style="background:#DCDCDC;" |[[Kawasaki disease]]
-| align="center" style="background:#F5F5F5;" + | −
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | −
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | −
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |±
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | −
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | −
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 119: / Line 473: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |History of administration of large quantities of [[blood]] products that contain [[sodium citrate]]
-| align="left" style="background:#F5F5F5;" + |
-* Associated with [[Renal insufficiency|renal impairment]]
 |-
-! rowspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" + |Drugs/Medication
+! align="center" style="background:#DCDCDC;" |[[Inflammatory bowel disease|IBD]]
-! align="center" style="background:#DCDCDC;" + |Chloruretic diuretics
+| align="center" style="background:#F5F5F5;" + |
-! align="left" style="background:#DCDCDC;" + |
+| align="center" style="background:#F5F5F5;" + |
-* Bumetanide
+| align="center" style="background:#F5F5F5;" + |
-* Chlorothiazide
+| align="center" style="background:#F5F5F5;" + |
-* Metolazone
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 143: / Line 495: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 152: / Line 503: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
-* Contraction alkalosis
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Penicillin
+! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 173: / Line 528: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 179: / Line 533: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Licorice
+! align="center" style="background:#DCDCDC;" |[[Hepatitis|Chronic hepatitis]]
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 200: / Line 559: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Laxative abuse
+! align="center" style="background:#DCDCDC;" |[[Sweet's syndrome|Sweet syndrome]]
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 231: / Line 593: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" + |Antacids
+! align="center" style="background:#DCDCDC;" |[[Gout|Acute gout]]
-! align="left" style="background:#DCDCDC;" + |
+| align="center" style="background:#F5F5F5;" + |
-* Aluminum hydroxide
+| align="center" style="background:#F5F5F5;" + |
-* Sodium polystyrene sulfonate
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 260: / Line 623: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category
+! rowspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection
-! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hydrogen loss
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Accumulation of base
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Chloride depletion
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous increased bone marrow production
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mineralocorticoid excess
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive increased bone marrow production
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fever
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dyspnea
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Edema
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Toxic/ill
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |BP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dehydration
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |HCO<sub>3</sub><sup>−</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |paCO<sub>2</sub>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |O<sub>2</sub>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Cl<sup>−</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |K<sup>+</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Na<sup>+</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ca<sup>+</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mg<sup>+</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Renin
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Bun
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Cr
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Urine Cl<sup>−</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard diagnosis
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other findings
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
 |-
-! rowspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Gastrointestinal origin
+! align="center" style="background:#DCDCDC;" |[[Infection|Acute bacterial]]
-! colspan="2" align="center" style="background:#DCDCDC;" + |Vomiting
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 300: / Line 672: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |toxic granulations, Döhle bodies, and cytoplasmic vacuoles in neutrophils
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 312: / Line 683: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Nasogastric tube suction
+! align="center" style="background:#DCDCDC;" |[[Infection|Chronic infection]]
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 326: / Line 703: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 338: / Line 713: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Zollinger−Ellison syndrome
+! align="center" style="background:#DCDCDC;" |[[Infection|Viral infection]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 366: / Line 744: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Bulimia
+! align="center" style="background:#DCDCDC;" |[[Granuloma|Granulomatous]] infections
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 383: / Line 766: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 392: / Line 774: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Congenital chloridorrhea
+! align="center" style="background:#DCDCDC;" |[[Bronchiectasis]]
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 418: / Line 804: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Pyloric stenosis
+! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Metabolic
-| align="center" style="background:#F5F5F5;" + | +
+! align="center" style="background:#DCDCDC;" |[[Diabetic coma]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 444: / Line 835: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Villous adenoma
+! align="center" style="background:#DCDCDC;" |[[Acidosis]]
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 470: / Line 865: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Gastrocystoplasty
+! align="center" style="background:#DCDCDC;" |[[Thyroid storm]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 496: / Line 895: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category
+! align="center" style="background:#DCDCDC;" |[[Cushing's syndrome|Hypercortisolism]]
-! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hydrogen loss
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Accumulation of base
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Chloride depletion
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mineralocorticoid excess
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fever
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dyspnea
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Edema
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Toxic/ill
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |BP
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dehydration
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |HCO<sub>3</sub><sup>−</sup>
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |paCO<sub>2</sub>
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |O<sub>2</sub>
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Cl<sup>−</sup>
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |K<sup>+</sup>
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Na<sup>+</sup>
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ca<sup>+</sup>
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mg<sup>+</sup>
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Renin
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Bun
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Cr
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Urine Cl<sup>−</sup>
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard diagnosis
+| align="center" style="background:#F5F5F5;" + |
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other findings
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 |-
-! rowspan="9" align="center" style="background:#4479BA; color: #FFFFFF;" + |Renal origin
+! align="center" style="background:#DCDCDC;" |[[Seizure|Seizures]]
-! colspan="2" align="center" style="background:#DCDCDC;" + |HTN
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 545: / Line 951: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Posthypercapnic state
+! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medication
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous increased bone marrow production
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive increased bone marrow production
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
+|-
+! align="center" style="background:#DCDCDC;" |[[Steroid|Steriod]]
+| align="center" style="background:#F5F5F5;" + |
+* Release of granulocytes from the bone marrow
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 576: / Line 1,017: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Hypomagnesemia
+! align="center" style="background:#DCDCDC;" |Myeloid growth factors
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 587: / Line 1,035: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Nl
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 593: / Line 1,040: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 600: / Line 1,046: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Nl
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Hypokalemia
+! align="center" style="background:#DCDCDC;" |[[Lithium]]
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 613: / Line 1,065: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Nl
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 619: / Line 1,070: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 626: / Line 1,076: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Nl
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Bartter's syndrome
+! align="center" style="background:#DCDCDC;" |[[Cytokine|Cytokines]]
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Nl
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 652: / Line 1,106: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Nl
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Gitelman’s syndrome
+! align="center" style="background:#DCDCDC;" |[[Catecholamine|Catecholamines]] ([[epinephrine]])
-| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + |
+* Stimulation of bone marrow myelopoiesis
+* Egress into the circulation
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 680: / Line 1,139: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Renal artery stenosis
+! align="center" style="background:#DCDCDC;" |[[Tretinoin|ATRA]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 691: / Line 1,157: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 701: / Line 1,166: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Nl
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Liddle syndrome
+! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous increased bone marrow production
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive increased bone marrow production
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
+|-
+! align="center" style="background:#DCDCDC;" |[[Allergy]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 732: / Line 1,230: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Renal tumors
+! align="center" style="background:#DCDCDC;" |Post [[splenectomy]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 758: / Line 1,260: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! rowspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + |Endocrine
+! align="center" style="background:#DCDCDC;" |[[Down syndrome]]
-! colspan="2" align="center" style="background:#DCDCDC;" + |Cushing's syndrome
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 770: / Line 1,278: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 780: / Line 1,287: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Nl
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! rowspan="2" align="center" style="background:#DCDCDC;" + |Hyperaldosteronism
+! align="center" style="background:#DCDCDC;" |[[Smoking|Cigarette smoking]]
-! align="center" style="background:#DCDCDC;" + |Primary
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 797: / Line 1,309: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↑
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 803: / Line 1,314: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Nl
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" + |Secondary
+! align="center" style="background:#DCDCDC;" |[[Stress (medicine)|Stress]]/[[Physical exercise|exercise]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 829: / Line 1,342: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 838: / Line 1,350: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! rowspan="2" align="center" style="background:#DCDCDC;" + |Adrenal enzyme defects
+! align="center" style="background:#DCDCDC;" |[[Infant|Infancy]]
-! align="center" style="background:#DCDCDC;" + |11β−Hydroxylase deficiency
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 856: / Line 1,373: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" + |17α−Hydroxylase deficiency
+! align="center" style="background:#DCDCDC;" |[[Pregnancy]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 882: / Line 1,403: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |↓
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! colspan="2" align="center" style="background:#DCDCDC;" + |Hypercalcemia/hypoparathyroidism
+! align="center" style="background:#DCDCDC;" |[[Platelet]] clumping
+| align="center" style="background:#F5F5F5;" + |Spurious
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 917: / Line 1,440: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Systemic
+! align="center" style="background:#DCDCDC;" |[[Cryoglobulinemia|Mixed cryoglobulinemia]]
-! colspan="2" align="center" style="background:#DCDCDC;" + |Cystic fibrosis
+| align="center" style="background:#F5F5F5;" + |Spurious
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + | +
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 944: / Line 1,470: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-| align="left" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
-! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hydrogen loss
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Accumulation of base
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Chloride depletion
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous increased bone marrow production
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mineralocorticoid excess
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive increased bone marrow production
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fever
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dyspnea
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Edema
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Toxic/ill
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |BP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dehydration
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |HCO<sub>3</sub><sup>−</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |paCO<sub>2</sub>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |O<sub>2</sub>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Cl<sup>−</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |K<sup>+</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Na<sup>+</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ca<sup>+</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mg<sup>+</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Renin
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Bun
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Cr
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Urine Cl<sup>−</sup>
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard diagnosis
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
-! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other findings
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
 |}
-<references />

Sandbox: wdx causes: Difference between revisions

Latest revision as of 21:38, 17 September 2018

Differentiating Leukocytosis from Other Diseases

Navigation menu